Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. NovoCure's annualizedGross Profit for the quarter that ended in Mar. 2022 was $439.3 Mil.
NovoCure's average Total Assets over the quarter that ended in Mar. 2022 was $1,144.9 Mil. Therefore, NovoCure's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2022 was 38.37%.
NovoCure Gross-Profit-to-Asset % Historical Data
The historical data trend for NovoCure's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
NovoCure Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Gross-Profit-to-Asset %
44.36
55.54
64.14
50.65
38.34
NovoCure Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Gross-Profit-to-Asset %
40.88
38.77
37.30
36.65
38.37
Competitive Comparison
For the Medical Instruments & Supplies subindustry, NovoCure's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovoCure Gross-Profit-to-Asset % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, NovoCure's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where NovoCure's Gross-Profit-to-Asset % falls into.
NovoCure Gross-Profit-to-Asset % Calculation
NovoCure's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2021 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Mar. 2022) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
NovoCure Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of NovoCure's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
3.79(4.73%) Volume: 599,319 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:NVCR has been successfully added to your 
